| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ADK | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | SLC1A4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | CTD-2207O23.3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BTBD7 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | KIAA1211L | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | DAPK3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | USP54 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | DIABLO | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | TMEM55B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
